BEIJING, June 27 (Xinhua) -- China's securities regulator has approved the registration for the initial public offerings (IPOs) of two companies on the science and technology innovation board.
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd., a biopharmaceutical enterprise focusing on antibody drugs; and Wuxi Chipown Micro-electronics Limited, a high-tech company engaged in analog and mixed signal integrated circuit design, will be listed on the Shanghai Stock Exchange's sci-tech innovation board, commonly known as the STAR market, according to the China Securities Regulatory Commission.
The two companies and their underwriters will confirm the IPO dates and publish their prospectuses following discussions with the stock exchange.
The STAR market, inaugurated in June last year and designed to support companies in the high-tech and strategic emerging sectors, eases listing criteria but adopts higher requirements for information disclosure. Enditem
A single purchase
